How And Where To Buy Jakafi Online?
CanadianPharmacyWorld.com offers the brand Jakafi and its generic Ruxolitinib Phosphate at a considerable discount. A valid prescription is required. We are CIPA-approved and provide a vast selection of
Cancer medications at huge savings. At the Canadian pharmacy world, your health is our priority. For further information or any inquiries, kindly reach us via mail, fax, or dial the toll-free number 1866-485-7979.
Are there Alternative Names for the brand Jakafi?
The brand Jakafi is available from Canada and manufactured by Novartis. The generic Ruxolitinib Phosphate is currently unavailable (at this pharmacy).
What Dosages and Forms Are Jakafi Available in?
The brand Jakafi is available in the strength of 5 mg, 10 mg, 15 mg, and 20 mg tablets.
What is the Jakafi Used for?
Jakafi (Ruxolitinib Phosphate) is a prescription medication used to treat intermediate or high-risk types of myelofibrosis in adults. Myelofibrosis is a type of bone marrow cancer. This condition scars the bone marrow, making it hard to make healthy blood cells. Jakafi may be used to treat primary myelofibrosis, post-polycythemia vera myelofibrosis, and post-essential thrombocythemia myelofibrosis. The drug is also used to treat polycythemia vera in adults who have already been treated with a medicine called hydroxyurea but didn't work well enough or were unable to tolerate it. Jakafi is also used to treat acute graft versus host disease (aGVHD) in adults and children 12 years of age and older who have taken corticosteroids and did not work well enough. The active ingredient in Jakafi is Ruxolitinib Phosphate. Ruxolitinib Phosphate belongs to a class of drugs called Janus-Kinase inhibitors. It works by inhibiting Janus kinases (JAKs), which are enzymes involved in the production of blood cells and the inflammatory process. By blocking these enzymes, Jakafi can help to reduce the symptoms and complications of the conditions it treats.
What are the Possible Side Effects of Jakafi?
If you experience any of the following common side effects, contact your doctor or pharmacist immediately:
• Bruising;
• Diarrhea;
• Dizziness;
• Headache;
• Infection;
• Low blood cell counts
Stop using Jakafi and contact your doctor right away if you have any of the severe side effects such as:
• Changes in the size, shape, or color of skin lesions or moles;
• Cold sores around the mouth;
• Problems with speech, thought, muscle movement, or vision;
• Signs of an allergic reaction, including rash, breathing difficulties, and itching of the face, tongue, or throat;
• Signs of tuberculosis, such as fever, cough, appetite loss, weight loss, and tiredness
This is not a complete list of Jakafi's adverse effects. Kindly contact your doctor or pharmacist if any of the above-listed side effects last longer than usual or worsen.
Are there any precautions or drug interactions for Jakafi?
Before using this medication, tell your doctor or pharmacist if you are allergic to Jakafi or have other problems when using Jakafi. It is crucial to continue using this medication exactly as your doctor prescribes. Jakafi comes as a tablet. Swallow the tablet whole with a glass of water, according to your doctor's instructions. You may take this medicine with or without food. Jakafi tablet may also be given through a nasogastric (NG) feeding tube. Your dose and length of treatment will depend on the condition you are treating. Do not stop using this medicine suddenly. Stopping this drug suddenly may make your symptoms worse. If you want to stop the drug, talk to your doctor about tapering your dose. Your doctor may give you other medicines to help prevent infection. Keep taking your medication for as long as your doctor has prescribed them. If you are on dialysis, take Jakafi after your dialysis. Avoid taking grapefruit products when using Ruxolitinib Phosphate. Grapefruit may interact with the medicine and increase your risk of side effects. To be sure Jakafi is helping your condition and not causing harmful effects, your blood will need to be tested often. This will help your doctor determine the best dose for you to use. When you first start taking this medicine, your blood will need to be tested every 2 to 4 weeks. Do not miss any follow-up visits to your doctor.
You should not use Jakafi and inform your doctor about your medical history, especially if you have or have had:
• Any other blood cancer;
• Any type of infection;
• Heart problems;
• High cholesterol;
• Kidney disease;
• Liver disease;
• Low white or red blood cell counts;
• Shingles;
• Tuberculosis
Tell your doctor if you are pregnant or planning to become pregnant. It is unknown if Ruxolitinib Phosphate will harm an unborn baby. Discuss the benefits and risks of using this medicine in pregnancy with your doctor. Inform your doctor if you are breastfeeding. Ruxolitinib Phosphate passes into breast milk, and it may harm a nursing infant. Do not breastfeed while using Jakafi and for at least 2 weeks after your last dose. Jakafi's use in myelofibrosis and polycythemia vera is generally not approved for patients under 18 years old.
Tell your doctor about all the medications you use, including prescriptions, over-the-counter medications, herbal products, and vitamin supplements, to prevent drug interactions that might be fatal to your health. This drug interaction may make your drug less effective, cause adverse effects, or potentiate other drugs' actions. There may be a drug interaction between Jakafi and other drugs, such as Eliquis, rosuvastatin, fluconazole, erythromycin, Prozac, ritonavir, Verapamil, cimetidine, carbamazepine, phenytoin, warfarin, etc.
Jakafi Storage and Safety Information
Store Jakafi at room temperature, away from light, moisture, and heat. Keep Jakafi and all medicines out of reach of children.
Blog Post
Boost Your Sense of Smell to Lower Blood PressureThe content on this page has been supplied to canadianpharmacyworld.com by an independent third party contracted to provide information for our website. Canadianpharmacyworld.com relies on these third parties to create and maintain this information and cannot guarantee the accuracy or reliability of the information that has been provided to us.
The drug information provided here is only a summary and does not contain all the list of possible side effects and drug interactions regarding this medication. Be sure to contact your doctor or pharmacist if you have any specific question or concern. If you require any advice or information about the drugs on this page, a medical condition or treatment advice, you should always speak to a healthcare professional.
Please note that not all products, including any referenced in this page, are shipped by our affiliated Canadian Pharmacy. We are affiliated with other dispensaries that ship product to our customers from the following jurisdictions: Canada, Singapore, New Zealand, Turkey, Mauritius, India, and United Kingdom. The items in your order maybe shipped from any of the above jurisdictions. The products are sourced from various countries as well as those listed above. Rest assured, we only affiliate with our authorized dispensaries that procure product through reliable sources.